Celldex Therapeutics Inc. (CLDX)
NASDAQ: CLDX
· Real-Time Price · USD
25.44
0.50 (2.00%)
At close: Aug 15, 2025, 2:57 PM
Celldex Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 23.04M | 17.14M | 28.36M | 36.4M | 42.74M | 115.08M | 34.81M | 21.13M | 28.22M | 54.12M | 29.43M | 18.58M | 28.4M | 25.29M | 39.14M | 72.18M | 43.45M | 69.31M |
Short-Term Investments | 607.29M | 656.15M | 696.92M | 719.6M | 759.58M | 708.77M | 386.88M | 214.21M | 224.47M | 224.26M | 275.52M | 304.89M | 328.42M | 355.18M | 369.11M | 350.9M | 120.59M | 106.77M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 9.3M | 10.41M | 9.75M | 9.75M | 107K | 107K | 107K | 107K | n/a | n/a | n/a | 104K | 104K | 104K | n/a | 98K | 41K | 41K |
Receivables | 90K | 1.06M | 700K | 852K | 1.53M | 2.67M | 2.63M | 252K | 118K | 1.31M | 347K | 189K | 97K | 243K | 172K | 197K | 496K | 1.83M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -118K | -1.31M | -347K | n/a | n/a | n/a | -172K | n/a | n/a | n/a |
Other Current Assets | 17.98M | 19.4M | 21.18M | 21.99M | 8.12M | 8.81M | 7.37M | 10.33M | 12.01M | 9.9M | 12.39M | n/a | 11.06M | 9.99M | n/a | 3.27M | 3.07M | 3.59M |
Total Current Assets | 648.4M | 693.76M | 747.16M | 778.84M | 811.98M | 835.32M | 431.69M | 245.93M | 264.82M | 289.6M | 317.69M | 334.6M | 367.98M | 390.7M | 410.84M | 426.56M | 167.61M | 181.5M |
Property-Plant & Equipment | 7.51M | 8.12M | 8.24M | 7.4M | 6.31M | 6.23M | 6.64M | 7.03M | 3.94M | 4M | 3.75M | 7.33M | 7.69M | 6.05M | 3.55M | 6.36M | 6.21M | 6.83M |
Goodwill & Intangibles | 27.19M | 27.19M | 27.19M | 27.19M | 27.19M | 27.19M | 27.19M | 27.19M | 30.55M | 30.93M | 31.3M | 27.19M | 27.19M | 27.19M | 30.26M | 27.19M | 30.69M | 30.69M |
Total Long-Term Assets | 44M | 45.71M | 45.18M | 44.34M | 33.61M | 33.52M | 33.93M | 34.32M | 34.49M | 34.92M | 35.04M | 34.63M | 34.98M | 33.34M | 33.81M | 33.65M | 36.95M | 37.57M |
Total Assets | 692.41M | 739.47M | 792.34M | 823.18M | 845.59M | 868.85M | 465.63M | 280.26M | 299.31M | 324.52M | 352.74M | 369.23M | 402.96M | 424.04M | 444.65M | 460.2M | 204.55M | 219.06M |
Account Payables | 2.07M | 3.41M | 3.27M | 1.11M | 3.8M | 3.23M | 3.49M | 3.59M | 881K | 3.37M | 3.34M | 2.27M | 902K | 1.02M | 1.23M | 836K | 685K | 997K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 18.47M | 12.26M | n/a | n/a | 11.43M | n/a | n/a | 12M | 10.25M | 7.85M | 7.02M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | 1.64M | 1.61M | 1.55M | 1.53M | n/a | 1.45M | 1.44M | 1.43M | 1.8M | 1.75M | 1.37M | 1.33M | 1.37M |
Other Current Liabilities | 930K | 1.65M | 942K | 1.4M | 3.67M | 2.23M | 15.05M | -15.79M | -552K | 978K | 4.85M | -286K | 14.97M | 703K | -192K | 355K | 3.29M | 6.21M |
Total Current Liabilities | 32.96M | 32.02M | 39.5M | 32.09M | 27.66M | 26.29M | 31.13M | 27.84M | 15.65M | 15.22M | 18.61M | 16.29M | 29.95M | 14.56M | 16.53M | 14.18M | 14.49M | 16.98M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 2.54M | 2.54M | 3.47M | 3.47M | 3.47M | 3.47M | 4.4M | 4.4M | 4.4M | 4.4M | 5.33M | 5.33M | 5.33M | 10.54M | 7.35M | 7.6M | 6.33M | 6.16M |
Total Long-Term Liabilities | 4.04M | 4.47M | 5.83M | 5.18M | 4.27M | 3.94M | 5.33M | 5.7M | 6.13M | 6.56M | 7.92M | 7.52M | 7.92M | 11.38M | 8.65M | 9.31M | 7.78M | 7.92M |
Total Liabilities | 37M | 36.49M | 45.34M | 37.27M | 31.93M | 30.23M | 36.46M | 33.54M | 21.77M | 21.78M | 26.53M | 23.81M | 37.87M | 25.94M | 25.18M | 23.49M | 22.27M | 24.9M |
Total Debt | 3.03M | 3.43M | 3.81M | 3.09M | 2.38M | 2.11M | 2.54M | 2.85M | 3.25M | 3.65M | 4.03M | 3.63M | 4.01M | 2.64M | 3.04M | 3.08M | 2.78M | 3.14M |
Common Stock | 66K | 66K | 66K | 66K | 66K | 66K | 56K | 47K | 47K | 47K | 47K | 47K | 47K | 47K | 47K | 47K | 40K | 40K |
Retained Earnings | -1.67B | -1.61B | -1.56B | -1.51B | -1.47B | -1.43B | -1.4B | -1.35B | -1.32B | -1.29B | -1.26B | -1.23B | -1.2B | -1.17B | -1.14B | -1.12B | -1.1B | -1.09B |
Comprehensive Income | 3.34M | 3.57M | 3.31M | 5.29M | 1.78M | 2.24M | 3.31M | 2.13M | 2.07M | 2.12M | 1.26M | -112K | -417K | 112K | 1.89M | 2.55M | 2.59M | 2.59M |
Shareholders Equity | 655.41M | 702.98M | 747M | 785.9M | 813.66M | 838.61M | 429.17M | 246.72M | 277.54M | 302.74M | 326.2M | 345.42M | 365.09M | 398.1M | 419.48M | 436.71M | 182.28M | 194.17M |
Total Investments | 607.29M | 656.15M | 696.92M | 719.6M | 754.78M | 704.07M | 386.88M | 214.21M | 224.47M | 224.26M | 275.52M | 304.89M | 328.42M | 355.18M | 369.11M | 350.9M | 120.59M | 106.77M |